Skip to main content
. 2020 Feb 11;12:1029–1038. doi: 10.2147/CMAR.S234448

Table 2.

Univariate Analysis of Risk Factors Associated with Postoperative Complications

Characteristics All (n=154) Postoperative Complications P-value
Yes (n=80) No (n=74)
Age,year 64.9±11.4 64.4±12.2 65.4±10.6 0.607
Sex,n(%) 0.004
 Male 95(61.7) 58(72.5) 37(50)
 Female 59(38.3) 22(27.5) 37(50)
Body mass index, kg/m2 23.7±3.5 23.4±3.6 23.9±3.5 0.382
Chronic disease,n(%) 0.907
 Hypertension 59(38.3) 28(35.0) 31(41.9)
 Diabetes mellitus 25(16.2) 15(18.8) 10(13.5)
 Dyslipidemia 10(6.5) 5(6.3) 5(6.8)
 Hepatocirrhosis 1(0.6) 1(1.3) 0(0.0)
Preoperative CRP,mg/L 6.9±10.5 8.7±13.4 4.9±5.2 0.018
Preoperative albumin, g/L 37.1±3.7 36.5±4.2 37.8±3.1 0.032
Preoperative CAR 0.2±0.4 0.3±0.5 0.1±0.1 0.019
Preoperative mGPS≥1,n(%) 26(16.9) 21(26.3) 5(6.8) 0.002
Surgical approach, n(%) 0.782
 Laparoscopy 132(85.7) 70(87.5) 62(83.8)
 Converted laparoscopy 8(5.2) 4(5.0) 4(5.4)
 Laparotomy 14(9.1) 6(7.5) 8(10.8)
Operative time, minutes 216.2±94.2 235.1±99.5 195.7±84.0 0.009
Estimated blood loss, mL 164.4±647.7 239.4±891.5 83.3±79.0 0.123
Location of the tumor,n(%) 0.152
 Colon 74(48.1) 34(42.5) 40(54.1)
 Rectum 80(51.9) 46(57.5) 34(45.9)
Neoadjuvant treatment,n(%) 9(5.8) 9(11.3) 0(0.0) 0.003
Pathological stage, n(%) 0.534
 pCR 2(1.3) 1(1.3) 1(1.4)
 0 1(0.6) 0(0.0) 1(1.4)
 I 42(27.3) 20(25.0) 22(29.7)
 II 49(31.8) 27(33.7) 22(29.7)
 III 46(29.9) 22(27.5) 24(32.4)
 IV 14(9.1) 10(12.5) 4(5.4)
CRP on POD3, mg/L 57.1±49.8 73.9±54.0 38.9±4.4 <0.001
Albumin on POD3, g/L 33.2±3.7 32.4±3.8 34.0±3.6 0.009
CAR on POD3 1.8±1.7 2.4±1.8 1.2±1.1 <0.001
poGPS≥1 on POD3,n(%) 20(13.0) 18(22.5) 2(2.7) <0.001

Notes: Data represent mean ± standard deviation or frequency, as appropriate.

Abbreviations: CRP, C-reactive protein; CAR, C-reactive protein/albumin ratio; mGPS, modified Glasgow Prognostic Score; pCR, pathologic complete response; POD, postoperative day; poGPS, postoperative Glasgow Prognostic Score.